Joseph Larmarange

PRINCESSE @ AIDS 2024 in Munich

Joseph LARMARANGE — 2024-07-23T15:46:03Z

AIDS 2024, the 25^th International AIDS Conference, was in Munich from 22 to 26 July 2024. Four posters were selected on abstract. In addition, main results from the ANRS 12381 PRINCESSE project were presented and discussed on the stand France.

Vulnerability and psychological distress of female sex workers in Côte d'Ivoire

Hasna Youssoufa , Marcelin N'Zebo Nouaman , Charlotte Bernard , Valentine Becquet , Patrick Coffie , Aline Agoua , Serge Eholié , Joseph Larmarange , Mélanie Plazy

AIDS 2024, the 25th International AIDS Conference, Jul 2024, Munich, Germany.

Poster de conférence

hal-04660379

‘Dirt just has to come down': body perceptions and lived experiences of female sex workers in Côte d'Ivoire (ANRS 12361 PrEP-CI and ANRS 12381 PRINCESSE projects)

Valentine Becquet , Evelyne Kissi , Mélanie Plazy , Marcelin N'Zebo Nouaman , Patrick Coffie , Aline Agoua , Serge Eholié , Joseph Larmarange

AIDS 2024, the 25th International AIDS Conference, Jul 2024, Munich, Germany.

Poster de conférence

hal-04660389

Facilitators and barriers to the enrolment and retention of female sex workers in a sexual health cohort (ANRS 12381 PRINCESSE) in San-Pedro, Côte d'Ivoire

Evelyne Kissi , Rose-Marcelle Dedocoton , Marcelin N'Zebo Nouaman , Mélanie Plazy , Patrick Coffie , Aline Agoua , Joseph Larmarange , Valentine Becquet

AIDS 2024, the 25th International AIDS Conference, Jul 2024, Munich, Germany.

Poster de conférence

hal-04660360

“We used to treat a bit blindly: it was a syndromic diagnosis”. Physicians' perceptions of comprehensive management of sexually transmitted infections among sex workers in Côte d'Ivoire

Marcelin N'Zebo Nouaman , Patrick Coffie , Mélanie Plazy , Valentine Becquet , Serge Eholié , Joseph Larmarange

AIDS 2024, the 25th International AIDS Conference, Jul 2024, Munich, Germany.

Poster de conférence

hal-04660367

ANRS 12381 PRINCESSE @ AFRAVIH 2024

Joseph LARMARANGE — 2024-04-09T16:46:34Z

La 12^e Conférence Internationale Francophone AFRAVIH s'est tenue du 16 au 19 avril 2024 à Youndé.

Session SP06 - Antirétroviraux : prévention et traitements 17 avril 2024 à 15h

« C'est difficile de la prendre tous les jours » : Initiations, arrêts précoces et perceptions de la prophylaxie pré-exposition (PrEP) orale parmi les travailleuses du sexe en Côte d'Ivoire

Valentine Becquet , Mélanie Plazy , Evelyne Kissi , Marcellin Nouaman , Patrick Coffie , Aline Agoua , Serge Eholié , Joseph Larmarange

12e Conférence Internationale Francophone AFRAVIH, AFRAVIH, Apr 2024, Yaoundé, Cameroun

Communication dans un congrès

hal-04539829

Session SP10 - Santé mentale 17 avril 2024 à 15h

Vulnérabilité et détresse psychologique des travailleuses du sexe en Côte d'Ivoire

Hasna Youssoufa , Marcellin Nouaman , Charlotte Bernard , Valentine Becquet , Patrick Coffie , Aline Agoua , Serge Eholié , Joseph Larmarange , Mélanie Plazy

12e Conférence Internationale Francophone AFRAVIH, AFRAVIH, Apr 2024, Yaoundé, Cameroun

Communication dans un congrès

hal-04539824

Session SP12 - Sciences humaines et sociales - Session Sandrine Musso 18 avril 2024 à 10h

Facilitateurs et freins à l'adhésion et au maintien des travailleuses du sexe dans une cohorte de santé sexuelle (projet ANRS 12381 Princesse) à San-Pedro en Côte d'Ivoire

Evelyne Kissi , Rose-Marcelle Dedocoton , Marcellin Nouaman , Mélanie Plazy , Patrick Coffie , Aline Agoua , Joseph Larmarange , Valentine Becquet

12e Conférence Internationale Francophone AFRAVIH, AFRAVIH, Apr 2024, Yaoundé, Cameroun

Communication dans un congrès

hal-04539831

Session SP17 - Santé sexuelle 2 18 avril 2024 à 15h

« Avant on traitait un peu à l'aveugle, c'était un diagnostic syndromique. » Perceptions des médecins dans une prise en charge globale des infections sexuellement transmissibles chez des travailleuses du sexe en Côte d'Ivoire

Marcellin Nouaman , Evelyne Kissi , Patrick Coffie , Mélanie Plazy , Valentine Becquet , Serge Eholié , Joseph Larmarange

12e Conférence Internationale Francophone AFRAVIH, AFRAVIH, Apr 2024, Yaoundé, Cameroun

Communication dans un congrès

hal-04539834

Promesses et défis de la santé communautaire

Joseph LARMARANGE — 2024-04-09T16:06:44Z

La mise en place d'une couverture sanitaire véritablement universelle est un des grands défis de notre époque face auquel la santé communautaire semble être une réponse adaptée. Conceptualisée à la fin des années 1980 pour améliorer l'accès aux services de santé primaires dans les pays à moyen et faible revenus, elle repose sur la participation des communautés dans le suivi de leur propre bien-être. Mais après plus de 30 ans d'existence, elle peine à être à la hauteur de ses ambitions d'universalité et d'efficacité. Quelles sont ses promesses et quels sont ses défis ? Tour d'horizon de la santé communautaire à travers le monde.

Santé sexuelle & Consentement : Introduction par le grand témoin

Joseph LARMARANGE — 2023-11-28T08:00:00Z

Santé sexuelle & Consentement · Introduction par le grand témoin

Joseph Larmarange

Colloque Santé sexuelle et consentement, URACA Basiliade; COREVIH IDF-Nord, Nov 2023, Paris, France

Communication dans un congrès

hal-04307854

Recherche interventionnelle : transformer des innovations efficaces en interventions efficientes

Joseph LARMARANGE — 2023-03-21T14:44:07Z

Communication orale réalisée le 21 mars 2023 dans le cadre des Journées scientifiques 2023 de l'ANRS|MIE à Paris.

Recherche interventionnelle : transformer des innovations efficaces en interventions efficiences

Joseph Larmarange

Journées scientifiques 2023 de l'ANRS | Maladies infectieuses émergentes, ANRS | MIE, Mar 2023, Paris, France

Communication dans un congrès

ird-04039578

Décrire les épidémies, Comprendre les populations : une démographie du VIH en Afrique subsaharienne

Joseph LARMARANGE — 2022-10-14T06:38:12Z

Habilitation à Diriger des Recherches soutenue le 12 octobre 2012 par Joseph Larmarange à l'Université Paris Cité.
Décrire les épidémies, Comprendre les populations : une démographie du VIH en Afrique subsaharienne
Joseph Larmarange Démographie. Université Paris Cité, 2022 HDR tel-03814024

- Publications / Afrique subsaharienne, ATLAS, CAP-CoV-Soignants-BF, DOD-CI (ANRS 12287 / 12323), ELIHoS (ANRS 12139), PrEP CI (ANRS 12361), Prévalences du VIH (ANRS 12114), prevR, PRINCESSE, TasP (ANRS 12249), Afrique du Sud, Burkina Faso, Côte d'Ivoire, Mali, Sénégal, Accès aux soins, Analyse de séquences, Approches biographiques, Approches communautaires, Autotests VIH, Cartographie, Cascade des soins, Comparaison de cohortes, Comportements sexuels, Démographie, Dépistage, EDS (Enquêtes Démographiques et de Santé), Enquêtes par téléphone, Enseignement académique, Lien vers les soins, Épidémiologie, Essais cliniques, Estimateurs à noyau (kernel density estimation), Femmes enceintes, Financement des programmes, Hépatites virales, Homo / Bisexualités, Identités sexuelles, Incidence du VIH, Interpolation spatiale, IST (Infections Sexuellement Transmissibles), Itinéraires thérapeutiques, Masculinités, Ménages, Mesure d'impact, Mesure des indicateurs, Méthodologie, Migrations, Observatoire de population, Partenaires sexuel(le)s, PrEP, Prévalence du VIH, Prévention, Prise en charge, Recherche interventionnelle, Recherche participative/communautaire, Recrutement « boules de neige », Représentations / Perceptions, Représentativité et Biais, Santé publique, Santé sexuelle, Structure des populations, Structures de santé, Surveillance sentinelle, Téléphones mobiles, Temporalités, Traitement antirétroviral (ARV), Travail du sexe, Treatment as Prevention (TasP), Universal Test & Treat (UTT), Usageres de drogue, VIH / SIDA

24th International AIDS Conference @ Montreal

Joseph LARMARANGE — 2022-08-08T18:58:39Z

Oral communications and poster presented at the 24^th International AIDS Conference 2022 in Montreal.

List of communications

Larmarange Joseph (2022) “Self-Testing, Empowerment and Self-Care: perspectives from lessons learned in implementing HIV self-testing in West Africa” (communication orale (symposium SA019), presented at the 24th International AIDS Conference, Montreal. https://programme.aids2022.org/Programme/Session/107.

Show/hide details

Larmarange - 2022 - Self-Testing, Empowerment and Self-Care perspecti.pdf 1.8 MiB

Nouaman Marcellin, Coffie Patrick A, Plazy Mélanie, Becquet Valentine, Agoua Aline, Zébago Clémence, Dao Hervé, Larmarange Joseph, Eholié Serge and ANRS 12381 PRINCESSE study group (2022) “Prevalence and incidence of sexually transmitted infections in a cohort of female sex workers in San Pedro, Côte d'Ivoire (ANRS 12381 PRINCESSE)” (poster), presented at the 24th International AIDS Conference, Montreal. https://programme.aids2022.org/Abstract/Abstract/?abstractid=6713.

Show/hide details

Abstract: BACKGROUND: The ANRS 12381 PRINCESSE study is an interventional single-arm cohort. Participants recruitment started in November 2019. The study aimed to evaluate a comprehensive and community-based care offer among FSWs aged '¥ 18 years in the San Pedro area. METHODS: Care services included quarterly syndromic screening for STIs, as well as vaginal and anal swabs for the screening of chlamydia trachomatis (CT) and neisseria gonorrhoea (NG) by polymerase chain reaction (PCR) at M0, M12 and M24. At the same visits, identification of dysplasias and precancerous lesions of the cervix was performed by visual inspection after applying acetic acid and Lugol's iodine. STIs were managed according to the national algorithm. We describe (i) the characteristics of cervical lesions as well as the prevalence of STIs (syndromic and PCR) and associated symptoms and (ii) the incidence of syndromic STIs during follow-up. RESULTS: In November 2021, 372 FSWs were included. The median age was 29 years, 34% had never been to school, 56% were Ivorian, and the median duration of sex work was 2 years. At inclusion, 4.7% [95% confidence interval: 2.8-7.5] had cervical lesions with 3.5% leukoplakia and 2.2% haemorrhagic cervical junction zone. The prevalence of syndromic STIs was 17.2% [13.0-22.6]; associated clinical signs were vaginal discharge (13.7%), vaginal ulceration (2.1%), lower abdominal pain (4.3%) and cervical inflammation (2.6%). The prevalence of anovaginal CT and NG were 8.7% [6.2- 12.1] and 10.4% [7.6- 13.9], respectively; clinical signs were found in 2.4% of CT-positive and 12.2% of NG-positive FSWs. Most FSWs with syndromic STIs did not have CT or NG infection. During the follow-up, 82 cases of syndromic STIs were observed per 209 person-years, i.e. an incidence of 39.1% [31.1- 49.0]. PCR data at M12 and M24 are being consolidated and will allow estimating the incidence of CT and NG. CONCLUSIONS: A high prevalence and incidence of syndromic STIs were observed among FSWs, highlighting the importance and the interest of a regular follow-up. The results also showed the predominantly asymptomatic nature of STIs discovered by PCR in this at-risk population and, therefore, the importance of coupling syndromic screening and PCR analyses.

Nouaman et al. - 2022 - Prevalence and incidence of sexually transmitted i.pdf 832 KiB

Plazy Mélanie, Nouaman Marcellin, Becquet Valentine, Agoua Aline, Zébago Clémence, Dao Hervé, Coffie Patrick A, Eholié Serge, Larmarange Joseph and ANRS 12381 PRINCESSE study group (2022) “Delays to PrEP initiation among female sex workers in Côte d'Ivoire (ANRS 12381 PRINCESSE project)” (poster), presented at the 24th International AIDS Conference, Montreal. https://programme.aids2022.org/Abstract/Abstract/?abstractid=6824.

Show/hide details

Abstract: BACKGROUND: To describe the delays to initiation of oral pre-exposure prophylaxis (PrEP) among female sex workers (FSW) in Côte d''Ivoire. METHODS: The ANRS 12381 PRINCESSE project is a single-arm interventional cohort aiming to evaluate the implementation of a comprehensive and community-based care offer among FSW aged '¥18 years in the San Pedro region since end-2019, through a mobile clinic operating on 10 prostitution sites (visited every two weeks). PrEP is offered to all HIV-positive FSW after verifying the creatinine level (results valid for one month). We described the time between FSW's interest for PrEP and PrEP initiation (or end of follow-up) among HIV- and hepatitis B virus-negative (HBsAg-) FSW included until end-October 2021. The probability of PrEP initiation since PrEP interest is described through a Kaplan-Meier curve censored on end-November 2021 (an analysis censored at the date of the last visit was also conducted). RESULTS: Of the 362 FSW included in the PRINCESSE cohort, 302 were HIV-/AgHBs-, and for 296 of them, PrEP was presented by medical staff (95.2% at inclusion). In total, 292 FSW expressed PrEP interest, and 192 (65.8%) initiated PrEP: 18 on the same day (the biological test having been performed during a previous visit), 148 during the next visit (median time since interest: 3 weeks [Inter-Quartile Range: 2-6]) and 26 during a subsequent visit (median time: 20 weeks [9-36]). The probability of PrEP initiation after PrEP interest was 39.0% at 1 month and 56.6% at 3 months (censoring on the date of the last visit, these proportions were 50.7% and 74.6%, respectively). Among the 100 FSW who did not initiate PrEP despite expressing interest, 68 were never seen again in the project; 4 declared that they were no longer interested in PrEP (median time since interest: 12 weeks [10-19]), 1 was tested HIV+ (delay of 2 weeks), and 27 were seen >1 month later (their biological tests were no longer valid). CONCLUSIONS: Despite strong PrEP interest among FSW, PrEP initiation remained suboptimal. Barriers to PrEP initiation should be more explored and considered to find appropriate solutions to make PrEP effective among this specific key population.

Plazy et al. - 2022 - Delays to PrEP initiation among female sex workers.pdf 484.6 KiB

Silhol Romain, Maheu-Giroux Mathieu, Soni Nirali, Simo Fotso Arlette, Rouveau Nicolas, Vautier Anthony, Doumenc-Aïdara Clémence, N'Guessan Kouakou, Mukandavire Christinah, Vickerman Peter, Keita Abdelaye, Ndour Cheikh Tidiane, Larmarange Joseph, Boily Marie Claude and ATLAS Team (2022) “Identifying population-specific HIV diagnosis gaps in Western Africa and assessing their impact on new infections: a modelling analysis for Côte d'Ivoire, Mali and Senegal” (poster), presented at the 24th International AIDS Conference, Montreal. https://programme.aids2022.org/Abstract/Abstract/?abstractid=4243.

Show/hide details

Abstract: BACKGROUND: Progress towards HIV elimination in Western Africa may be hindered by diagnosis gaps among people living with HIV (PLHIV), especially among key populations (KP) such as female sex workers (FSW), their clients, and men who have sex with men (MSM). We aimed to identify largest gaps in diagnosis by risk group in Mali, Côte d'Ivoire, and Senegal, and project their contribution to new HIV infections. METHODS: Deterministic models of HIV transmission/diagnosis/treatment that incorporate HIV transmission among KP were parameterized following comprehensive country-specific reviews of demographic, behavioural, HIV and intervention data. The model was calibrated to country- and group-specific empirical outcomes such as HIV incidence/prevalence, the fractions of PLHIV ever tested, diagnosed, and on treatment. We estimated the distribution of undiagnosed PLHIV by risk group in 2020 and the population-attributable-fractions (tPAFs) (i.e. fraction of new primary and secondary HIV infections 2020-2029 originating from risk groups of undiagnosed PLHIV). RESULTS: From 46% (95% UI: 38-58) to 69% (59-79) of undiagnosed PLHIV in 2020 were males, with the lowest proportion in Mali and the highest proportion in Senegal, where 41% (28-59) of undiagnosed PLHIV were MSM. Undiagnosed men are estimated to contribute most new HIV infections occurring over 2020-2029 (Table). Undiagnosed FSW and their clients contribute substantial proportions of new HIV infections in Mali, with tPAF=20% (10-36) and tPAF=43% (26-56), respectively, while undiagnosed MSM in Senegal are estimated to contribute half of new infections. A lower proportion of new HIV infections are transmitted by undiagnosed KP in Côte d'Ivoire (tPAF=21%(10-38)). CONCLUSIONS: Current HIV testing services and approaches are leaving members of KP behind. Increasing the availability of confidential HIV testing modalities in addition to traditional tests may substantially reduce gaps in HIV diagnosis and accelerate the decrease of new HIV infections in Western Africa since half of them could be transmitted by undiagnosed KP.

Silhol et al. - 2022 - Identifying population-specific HIV diagnosis gaps.pdf 288.9 KiB

Simo Fotso Arlette, Johnson Cheryl, Vautier Anthony, Kouamé Konan Blaise, Diop Papa Moussa, Silhol Romain, Maheu-Giroux Mathieu, Boily Marie-Claude, Rouveau Nicolas, Doumenc-Aïdara Clémence, Baggaley Rachel, Ehui Eboi, Larmarange Joseph and ATLAS Team (2022) “Estimating the impact of HIV self-testing on HIV testing services, diagnoses, and treatment initiation at the population-level with routine data: the example of the ATLAS program in Côte d'Ivoire” (poster), presented at the 24th International AIDS Conference, Montreal. https://programme.aids2022.org/Abstract/Abstract/?abstractid=5409.

Show/hide details

Abstract: BACKGROUND: HIV self-testing (HIVST) is a critical testing approach particularly for reaching those at HIV risk who are hesitant or unable to access existing services. While the discreet and flexible nature of HIVST is appealing to users, these features can limit the ability for programmes to monitor and estimate the population-level impacts of HIVST implementation. This study triangulates publicly available routine programme data from Côte d'Ivoire in order estimate the effects of HIVST distribution on access to testing, conventional testing (self-testing excluded), HIV diagnoses, and antiretroviral treatment (ART) initiations. METHODS: We used quarterly programmatic data (Q3-2019 to Q1-2021) from ATLAS, a project that aims to promote and implement network-based HIVST distribution in West Africa, in addition to routine HIV testing services program data obtained from the PEPFAR dashboard. We performed ecological time series regression using linear mixed-models. RESULTS: Between Q3-2019 and Q1-2021, 99,353 HIVST kits were distributed by ATLAS in 78 health districts included in the analysis. The results (Table 1) show a negative but non-significant effect of the number of ATLAS HIVST on the volume of conventional tests (-190), suggesting the possibility of a slight substitution effect. Despite this, the the beneficial effect on access to testing is significant: for each 1000 HIVST distributed via ATLAS, 390 to 590 additional HIV tests were performed if 60% to 80% of HIVST are used . The effect of HIVST on HIV diagnosis was significant and positive, with 8 additional diagnoses per 1,000 HIVST distributed. No effect of HIVST was observed on ART initiations. CONCLUSIONS: Our study provides a standard methodology for estimating the population-level impact of HIVST that can be used across countries. It shows that HIVST distribution was associated with increased access to HIV testing and diagnosis in Côte d'Ivoire. Wide-scale adoption of this method will improve HIVST data quality and inform evidence-based programming.

Simo Fotso et al. - 2022 - Estimating the impact of HIV self-testing on HIV t.pdf 541.2 KiB

Stannah James, Flores Anato Jorge Luis, Mitchell Kate M, Larmarange Joseph, Maheu-Giroux Mathieu and Boily Marie‐Claude (2022) “Improving our understanding of how structural determinants impact HIV epidemics: a scoping review of dynamic models to guide future research” (poster), presented at the 24th International AIDS Conference, Montreal. https://programme.aids2022.org/Abstract/Abstract/?abstractid=6564.

Show/hide details

Abstract: BACKGROUND: Dynamic models of HIV transmission have proven valuable tools for informing HIV prevention strategies. Including structural determinants in models is crucial to estimate their population-level impacts on HIV transmission and inform efforts towards HIV elimination. However, this is challenging due to a lack of coherent conceptual frameworks, limited understanding of their specific causal pathways, and few empirical estimates of their impacts on downstream mediators. METHODS: With the overarching aim to improve models, we conducted a scoping review of studies that used dynamic HIV transmission models to evaluate the impact of structural determinants. From included studies, we extracted information on the types of structural determinants and methods used to model their impacts on HIV transmission. We appraised studies on how they conceptualized structural exposures and represented their causal relationships over time within models. RESULTS: We identified 9 dynamic transmission modelling studies that incorporated structural determinants of HIV, including violence (N=3), incarceration (N=2), stigma (N=2), housing instability (N=2), migration (N=1), and education (N=1). Only one study modelled multiple determinants simultaneously. In most models, structural determinants were conceptualized using current, recent, non-recent and/or lifetime exposure categories. Modelled structural determinants largely impacted HIV transmission through mediated effects on one or more proximate risk factors, including sharing injection equipment, condom use, number of partners, and access to treatment. However, causal pathways were simplistic, with few mediators and/or lack of clear empirical justification. To measure impact, most studies simply assumed the elimination of structural determinants in counterfactual comparison scenarios. Few models included long-term and/or delayed effects of past, recurrent, or acute exposure, potentially overestimating impacts of determinants. CONCLUSIONS: Despite the importance of structural determinants for HIV prevention, methods for including them in dynamic HIV transmission models remain insufficient. Few studies have attempted to incorporate structural determinants in HIV models, and methods vary considerably. To improve inferences, models should adopt precise exposure definitions, deconstruct and estimate their complex causal pathways, and translate them into their mechanistic components. The need for development of coherent frameworks to conceptualize the synergistic interplay between strengthened empirical data analysis and the inclusion of structural determinants in dynamic models is pressing.

Stannah et al. - 2022 - Improving our understanding of how structural dete.pdf 538.6 KiB

Replay

Sida : en Afrique de l'Ouest, l'autotest oral, une petite révolution qui s'est invitée dans le dépistage

Joseph LARMARANGE — 2022-07-11T09:18:47Z

L'outil, moins invasif que le test sanguin, permet d'atteindre les milieux homosexuels, transgenres, les prostitués, isolés par la stigmatisation.

Des malades qui s'ignorent. En Afrique, un tiers des personnes infectées par le VIH ne connaissent pas leur statut sérologique. Il s'agit le plus souvent d'individus vulnérables et victimes de discrimination pour leur identité sexuelle ou leurs pratiques, qui demeurent ainsi dans le déni des risques auxquels ils sont exposés : bisexuels et homosexuels, femmes et hommes prostitués, usagers de drogues injectables.

C'est pour atteindre ces publics échappant aux campagnes classiques organisées par les ministères de la santé africains que l'ONG Solthis a imaginé le programme d'autodépistage Atlas pour l'Afrique de l'Ouest et centrale, avec le soutien financier de l'organisation Unitaid et de l'Agence française de développement (AFD). Le projet, lancé en 2018 en Côte d'Ivoire, au Mali et au Sénégal et qui vient de s'achever le 30 juin, a consisté en la distribution de 400 000 autotests oraux par le biais de pairs éducateurs.

« L'un des gros avantages de l'autodépistage, c'est son caractère confidentiel », explique Joseph Larmarange, démographe en santé publique et coordinateur des activités de recherche du projet Atlas. « Avant, je ne voulais pas faire de test. J'avais trop peur, témoigne ainsi Awa Camara, qui reçoit ses clients dans une chambre d'un quartier chaud de Bamako, au Mali. Avec l'autotest, j'ai sauté le pas. On le fait quand on est prêt dans sa tête et on est seul face au résultat. J'ai mis trois jours pour rappeler le pair éducateur qui m'a aidée quand le test de confirmation a révélé que j'avais le VIH. Aujourd'hui, je suis sous traitement et je vais bien. »

Lire la suite sur le site du Monde

Par Sandrine Berthaud-Clair, publié le 08 juillet 2022 à 18h00

Preferences and access to community-based HIV testing sites among men who have sex with men (MSM) in Côte d'Ivoire

Joseph LARMARANGE — 2022-06-30T09:49:27Z

Preferences and access to community-based HIV testing sites among men who have sex with men (MSM) in Cote d'Ivoire

Maxime Inghels , Arsene Kra Kouassi , Serge Niangoran , Anne Bekelynck , Severine Carilon , Lazare Sika , Mariatou Kone , Christine Danel , Annabel Desgrées du Loû , Joseph Larmarange

BMJ Open, 2022, 12 (6), ⟨10.1136/bmjopen-2021-052536⟩

Article dans une revue

hal-03757306

Authors

Maxime Inghels, Arsène Kra Kouassi, Serge Niangoran, Anne Bekelynck, Séverine Carilon, Lazare Sika, Mariatou Koné, Christine Danel, Annabel Degrées du Loû, Joseph Larmarange for the research team ANRS 12323 DOD-CI

Abstract

Objective Measuring access and preferences to Men who have Sex with Men focused community-based HIV testing sites (MSM-CBTS) in Côte d'Ivoire.

Design A respondent-driven sampling telephone survey.

Setting National survey conducted in 2018 in Côte d'Ivoire.

Participants 518 MSM aged over 18 years old.

Primary and secondary outcome measures Knowledge, practices, satisfaction and preferences regarding MSM-CBTS. Factors associated with MSM-CTBS access or knowledge and with HIV testing venue preferences were examined.

Results Only half of the respondents (47%) reported knowing of an MSM-CBTS. Of these, 79% had already attended one. Both knowing of and ever visiting an MSM-CBTS were significantly associated with a higher number of HIV tests performed in the past 12 months and having disclosed sexual orientation to one family member.
In terms of preferences, 37% of respondents said they preferred undifferentiated HIV testing sites (ie, ‘all patients' HIV testing sites), 34% preferred MSM-CBTS and 29% had no preference.
Those who reported being sexually attracted to women, being bisexual and those who did not know an MSM non-governmental organisation were less likely to prefer MSM-CBTS. MSM who preferred undifferentiated HIV testing sites mentioned the lack of discretion and anonymity of community-based sites and the desire to avoid the gaze of others.

Conclusion Community-based HIV testing is well suited for MSM who identify as homosexual and those close to the MSM community, while maintaining undifferentiated HIV testing is essential for others. Both types of activities need to be maintained and developed. Healthcare professionals in undifferentiated HIV testing sites need to be properly trained in the non-judgemental reception of MSM.

Dépistage communautaire et dépistage tout public : des offres complémentaires pour toucher tous les hommes ayant des relations sexuelles avec d'autres hommes (HSH)

Joseph LARMARANGE — 2022-05-19T09:38:15Z

Cette note de politique, préparée par PAC-CI, repose sur des résultats du projet DOD-CI ANRS 12323.

Dépistage communautaire et dépistage tout public : des offres complémentaires pour toucher tous les hommes ayant des relations sexuelles avec d'autres hommes (HSH)

Anne Bekelynck , Maxime Inghels , Joseph Larmarange

Note de politique PAC-CI #1, Programme PAC-CI. 2022

Rapport

ird-03882161